Agnieszka LemanskaView profile
Senior Lecturer
Dr. Agnieszka Lemanska is a Senior Lecturer in Health Data Science at the University of Surrey's School of Health Sciences within the Faculty of Health and Medical Sciences. She holds a joint appointment as a Senior Scientist at the National Physical Laboratory's Department of Data Science, where she contributes to improving healthcare data quality. Her research focuses on cancer-related studies using routinely collected healthcare data, with particular emphasis on early diagnosis and post-treatment outcomes. Dr. Lemanska earned her MSc in Pharmacy from the Medical University of Warsaw in 2005 and completed her PhD in Statistics and Machine Learning at the University of Bristol with GlaxoSmithKline funding. Her educational background bridges clinical pharmacy and advanced data science, creating a unique interdisciplinary perspective for her research. Her primary research interests center on routinely collected healthcare data, electronic healthcare records (EHRs), cancer-related primary care research, and data-driven early cancer diagnosis. She specializes in analyzing large databases of patient records including CPRD, ORCHID, and OpenSAFELY, with particular focus on pancreatic and prostate cancers. Her work addresses critical healthcare challenges including cancer diagnosis delays, treatment side effects, and healthcare system disruptions during the pandemic. Analysis of her recent publications reveals a strong focus on cancer epidemiology using large-scale electronic health records, with significant contributions to understanding pandemic impacts on cancer care. Her work demonstrates consistent methodological rigor across observational studies, systematic reviews, and clinical audits, with particular attention to real-world data applications in improving cancer diagnosis and treatment pathways. Dr. Lemanska actively contributes to multiple significant research projects including NPL Explorer's award for validating pancreatic cancer prediction algorithms, MRC Fellowship research on pandemic effects on cancer care, and EPSRC-funded PhD studentships investigating primary care data for early pancreatic cancer diagnosis. She has led important national audits on pancreatic enzyme prescribing and prostate cancer diagnosis disruptions during the pandemic. As an educator, she provides PhD, MSc, and BSc supervision while teaching across various healthcare programs including pharmacy, nursing, and physician associate curricula. Her international engagement includes serving as International Lead and Erasmus Coordinator for the School of Health Sciences, facilitating global academic collaborations and student exchanges.






